Jinhe Biotechnology CO., LTD. (002688.SZ)
CNY 7.18
(9.95%)
CNY 7.18
(9.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 86.45 Million CNY | -26.76% |
| 2022 | 118.04 Million CNY | 25.59% |
| 2021 | 93.99 Million CNY | -19.89% |
| 2020 | 117.32 Million CNY | -36.56% |
| 2019 | 184.93 Million CNY | 13.02% |
| 2018 | 163.62 Million CNY | 50.92% |
| 2017 | 108.42 Million CNY | -33.94% |
| 2016 | 164.12 Million CNY | 56.83% |
| 2015 | 104.65 Million CNY | 35.54% |
| 2014 | 77.2 Million CNY | -14.62% |
| 2013 | 90.43 Million CNY | 0.96% |
| 2012 | 89.57 Million CNY | 15.73% |
| 2011 | 77.4 Million CNY | 46.73% |
| 2010 | 52.75 Million CNY | 95.18% |
| 2009 | 27.02 Million CNY | 70.31% |
| 2008 | 15.86 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 45.87 Million CNY | 1.63% |
| 2024 Q3 | 22.74 Million CNY | -50.43% |
| 2024 Q1 | 45.14 Million CNY | 371.81% |
| 2023 Q2 | 52.43 Million CNY | 42.03% |
| 2023 Q1 | 36.92 Million CNY | 284.43% |
| 2023 FY | 86.45 Million CNY | -26.76% |
| 2023 Q4 | -16.6 Million CNY | -221.18% |
| 2023 Q3 | 13.7 Million CNY | -73.86% |
| 2022 Q4 | -20.01 Million CNY | -176.6% |
| 2022 FY | 118.04 Million CNY | 25.59% |
| 2022 Q3 | 26.13 Million CNY | -52.41% |
| 2022 Q2 | 54.92 Million CNY | 26.26% |
| 2022 Q1 | 43.49 Million CNY | 428.85% |
| 2021 FY | 93.99 Million CNY | -19.89% |
| 2021 Q2 | 32.31 Million CNY | -53.84% |
| 2021 Q3 | 14.95 Million CNY | -53.71% |
| 2021 Q1 | 70 Million CNY | 354.92% |
| 2021 Q4 | -13.22 Million CNY | -188.42% |
| 2020 Q2 | 40.92 Million CNY | -24.31% |
| 2020 Q1 | 54.07 Million CNY | 29.74% |
| 2020 Q4 | 15.38 Million CNY | 121.99% |
| 2020 FY | 117.32 Million CNY | -36.56% |
| 2020 Q3 | 6.93 Million CNY | -83.06% |
| 2019 Q2 | 67.3 Million CNY | 78.37% |
| 2019 FY | 184.93 Million CNY | 13.02% |
| 2019 Q4 | 41.68 Million CNY | 9.05% |
| 2019 Q3 | 38.21 Million CNY | -43.21% |
| 2019 Q1 | 37.73 Million CNY | 8.66% |
| 2018 Q2 | 54.35 Million CNY | 76.38% |
| 2018 Q1 | 30.81 Million CNY | 236.25% |
| 2018 Q4 | 34.72 Million CNY | -20.58% |
| 2018 FY | 163.62 Million CNY | 50.92% |
| 2018 Q3 | 43.72 Million CNY | -19.56% |
| 2017 Q4 | 9.16 Million CNY | -59.17% |
| 2017 Q2 | 35.78 Million CNY | -12.79% |
| 2017 FY | 108.42 Million CNY | -33.94% |
| 2017 Q1 | 41.02 Million CNY | 0.91% |
| 2017 Q3 | 22.44 Million CNY | -37.26% |
| 2016 Q4 | 40.65 Million CNY | 39.04% |
| 2016 FY | 164.12 Million CNY | 56.83% |
| 2016 Q3 | 29.24 Million CNY | -33.06% |
| 2016 Q2 | 43.68 Million CNY | -13.57% |
| 2016 Q1 | 50.54 Million CNY | 40.42% |
| 2015 Q2 | 27.33 Million CNY | 15.84% |
| 2015 Q1 | 23.59 Million CNY | 56.19% |
| 2015 FY | 104.65 Million CNY | 35.54% |
| 2015 Q4 | 35.99 Million CNY | 102.95% |
| 2015 Q3 | 17.73 Million CNY | -35.11% |
| 2014 Q4 | 15.1 Million CNY | 17.3% |
| 2014 FY | 77.2 Million CNY | -14.62% |
| 2014 Q2 | 28 Million CNY | 31.98% |
| 2014 Q1 | 21.22 Million CNY | -14.21% |
| 2014 Q3 | 12.87 Million CNY | -54.02% |
| 2013 Q3 | 20.68 Million CNY | -22.58% |
| 2013 Q4 | 24.73 Million CNY | 19.56% |
| 2013 FY | 90.43 Million CNY | 0.96% |
| 2013 Q1 | 18.28 Million CNY | -37.77% |
| 2013 Q2 | 26.72 Million CNY | 46.16% |
| 2012 Q2 | 28.92 Million CNY | 29.88% |
| 2012 Q4 | 29.38 Million CNY | 226.19% |
| 2012 Q1 | 22.26 Million CNY | -16.56% |
| 2012 Q3 | 9 Million CNY | -68.86% |
| 2012 FY | 89.57 Million CNY | 15.73% |
| 2011 Q4 | 26.68 Million CNY | 701.51% |
| 2011 Q3 | 3.32 Million CNY | 0.0% |
| 2011 FY | 77.4 Million CNY | 46.73% |
| 2010 FY | 52.75 Million CNY | 95.18% |
| 2009 FY | 27.02 Million CNY | 70.31% |
| 2008 FY | 15.86 Million CNY | 0.0% |